Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion

Hepatology

Volumn 53, Issue 6, 2011, Pages 1846-1853

  Petrovic, Danijela ^a   Stamataki, Zania ^b   Dempsey, Eugene ^a   Golden Mason, Lucy ^c,d   Freeley, Michael ^a   Doherty, Derek ^a   Prichard, David ^a   Keogh, Catherine ^a,c   Conroy, Jennifer ^a   Mitchell, Siobhan ^a   Volkov, Yuri ^a   Mckeating, Jane A ^b   O'Farrelly, Cliona ^a,c   Kelleher, Dermot ^a   Long, Aideen ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; GLYCOPROTEIN E2; INTERLEUKIN 2; METHYL BETA CYCLODEXTRIN; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA INHIBITOR; TETRASPANIN;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC TRANSCRIPTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID RAFT; LIVER BIOPSY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SERUM; T LYMPHOCYTE; VIRUS PARTICLE; VIRUS PATHOGENESIS;

ADAPTIVE IMMUNITY; ANTIGENS, CD; BIOPSY; CELL LINE, TUMOR; CELLS, CULTURED; HEPACIVIRUS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERLEUKIN-2; LIVER; MEMBRANE MICRODOMAINS; PROTEIN KINASE C; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS;

EID: 79957504614     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24327     Document Type: Article

References (41)

1. Wang C, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol 1993; 67: 3338-3344.
2. Brazzoli M, Crotta S, Bianchi A, Bagnoli F, Monaghan P, Wileman T, et al. Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell line. J Hepatol 2007; 46: 53-59.
3. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. HEPATOLOGY 2005; 42: 962-973.
4. Stamataki Z, Grove J, Balfe P, McKeating JA. Hepatitis C virus entry and neutralization. Clin Liver Dis 2008; 12: 693-712.
5. Petracca R, Falugi F, Galli G, Norais N, Rosa D, Campagnoli S, et al. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol 2000; 74: 4824-4830.
6. Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998; 16: 89-109.
7. McHutchison JG. Understanding hepatitis C. Am J Manag Care 2004; 10: S21-S29.
8. Mazzaro C, Tirelli U, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later. Dig Liver Dis 2005; 37: 219-226.
9. Gale M Jr, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature 2005; 436: 939-945.
10. Burke KP, Cox AL. Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence. Immunol Res 2010; 47: 216-227.
11. Horner SM, Gale M Jr. Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J Interferon Cytokine Res 2009; 29: 489-498.
12. Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994; 68: 8056-8063.
13. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278: 1447-1450.
14. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194: 1395-1406.
15. Volkov Y, Long A, Freeley M, Golden-Mason L, O'Farrelly C, Murphy A, et al. The hepatitis C envelope 2 protein inhibits LFA-1-transduced protein kinase C signaling for T-lymphocyte migration. Gastroenterology 2006; 130: 482-492.
16. Long A, Kelleher D, Lynch S, Volkov Y. Cutting edge: protein kinase C beta expression is critical for export of Il-2 from T cells. J Immunol 2001; 167: 636-640.
17. Dreikhausen UE, Gorf K, Resch K, Szamel M. Protein kinase Cbeta1, a major regulator of TCR-CD28-activated signal transduction leading to IL-2 gene transcription and secretion. Int Immunol 2003; 15: 1089-1098.
18. Semmo N, Day CL, Ward SM, Lucas M, Harcourt G, Loughry A, et al. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. HEPATOLOGY 2005; 41: 1019-1028.
19. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999; 117: 933-941.
20. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791-796.
21. Cao J, Zhao P, Miao XH, Zhao LJ, Xue LJ, Qi Zt Z. Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81. Cell Res 2003; 13: 473-479.
22. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309: 623-626.
23. Wack A, Soldaini E, Tseng C, Nuti S, Klimpel G, Abrignani S. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur J Immunol 2001; 31: 166-175.
24. Huse M, Lillemeier BF, Kuhns MS, Chen DS, Davis MM. T cells use two directionally distinct pathways for cytokine secretion. Nat Immunol 2006; 7: 247-255.
25. Urbani S, Amadei B, Fisicaro P, Tola D, Orlandini A, Sacchelli L, et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. HEPATOLOGY 2006; 44: 126-139.
26. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002; 169: 3447-3458.
27. Radziewicz H, Ibegbu CC, Hon H, Bedard N, Bruneau J, Workowski KA, et al. Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling. J Immunol 2010; 184: 2410-2422.
28. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006; 12: 1301-1309.
29. Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 2007; 81: 9249-9258.
30. Fuller MJ, Hildeman DA, Sabbaj S, Gaddis DE, Tebo AE, Shang L, et al. Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J Immunol 2005; 174: 5926-5930.
31. Fuller MJ, Zajac AJ. Ablation of CD8 and CD4 T cell responses by high viral loads. J Immunol 2003; 170: 477-486.
32. Iyasere C, Tilton JC, Johnson AJ, Younes S, Yassine-Diab B, Sekaly RP, et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol 2003; 77: 10900-10909.
33. Semmo N, Krashias G, Willberg C, Klenerman P. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection. J Viral Hepat 2007; 14: 492-502.
34. Rajendran L, Simons K. Lipid rafts and membrane dynamics. J Cell Sci 2005; 118: 1099-1102.
35. Crotta S, Brazzoli M, Piccioli D, Valiante NM, Wack A. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection. J Hepatol 2010; 52: 183-190.
36. Yu HY, Bement WM. Control of local actin assembly by membrane fusion-dependent compartment mixing. Nat Cell Biol 2007; 9: 149-159.
37. Djordjevic JT, Schibeci SD, Stewart GJ, Williamson P. HIV type 1 Nef increases the association of T cell receptor (TCR)-signaling molecules with T cell rafts and promotes activation-induced raft fusion. AIDS Res Hum Retroviruses 2004; 20: 547-555.
38. Cho NH, Kingston D, Chang H, Kwon EK, Kim JM, Lee JH, et al. Association of herpesvirus saimiri tip with lipid raft is essential for downregulation of T-cell receptor and CD4 coreceptor. J Virol 2006; 80: 108-118.
39. Avota E, Muller N, Klett M, Schneider-Schaulies S. Measles virus interacts with and alters signal transduction in T-cell lipid rafts. J Virol 2004; 78: 9552-9559.
40. Alric L, Thebault S, Peron JM, Balard P, Metivier S, Pipy B, et al. Pilot study of interferon-alpha-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1. J Viral Hepat 2006; 13: 139-144.
41. Glesby MJ, Bassett R, Alston-Smith B, Fichtenbaum C, Jacobson EL, Brass C, et al. Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. J Infect Dis 2005; 191: 686-693.